findmyKOL

Vishva Dev, MD

Basic profile

Los Robles Hospital & Medical Center

ORCIDNone on fileNPI
RegionThousand Oaks, CA · WestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Vishva Dev is a Cardiology physician affiliated with Los Robles Hospital & Medical Center. OpenAlex indexes 29 publications with 656 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
29publications

Distinct works indexed by OpenAlex.

656citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
27companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

227 W Janss Rd
Suite 360
Thousand Oaks, CA 913601848

Telephone

805-778-1111

Registry record last updated 17 Dec 2015.

View the NPPES registry record

Industry payments

27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    81.6%
    Adenosine Receptor Agonist22.5%
    Regadenoson100%
    Part B, office-administered513 patients
    Statin13.3%
    Rosuvastatin Calcium49%Atorvastatin Calcium42%Simvastatin6%Pravastatin Sodium2%Pitavastatin Calcium2%
    Part D<11 patients

    + 17 more classes in this area

  • Blood & clotting

    15.8%
    P2Y12 inhibitor7.7%
    Clopidogrel68%Brilinta23%Prasugrel Hcl9%
    Part D138 patients
    Factor Xa inhibitor7.5%
    Eliquis53%Xarelto47%
    Part D100 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    2%
    Potassium supplement0.6%
    Potassium Chloride100%
    Part D16 patients
    SGLT2 inhibitor0.5%
    Farxiga100%
    Part D14 patients

    + 4 more classes in this area

Where care is delivered (Part B)4.4% facility · 95.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”